Nenad Blau practices in Heidelberg, Germany. Blau is rated as an Elite expert by MediFind in the treatment of Dihydropteridine Reductase Deficiency. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Phenylketonuria (PKU), Dihydropteridine Reductase Deficiency, Inborn Amino Acid Metabolism Disorder, and GTP Cyclohydrolase 1 Deficiency.
His clinical research consists of co-authoring 127 peer reviewed articles in the past 15 years. In particular, he has co-authored 65 articles in the study of Dihydropteridine Reductase Deficiency.
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.